Lantern Pharma Inc (LTRN)
6.15
+0.66
(+12.02%)
USD |
NASDAQ |
May 03, 16:00
6.19
+0.04
(+0.65%)
After-Hours: 20:00
Lantern Pharma Price to Book Value: 1.615 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.615 |
| May 02, 2024 | 1.442 |
| May 01, 2024 | 1.415 |
| April 30, 2024 | 1.339 |
| April 29, 2024 | 1.294 |
| April 26, 2024 | 1.444 |
| April 25, 2024 | 1.434 |
| April 24, 2024 | 1.413 |
| April 23, 2024 | 1.515 |
| April 22, 2024 | 1.502 |
| April 19, 2024 | 1.402 |
| April 18, 2024 | 1.515 |
| April 17, 2024 | 1.573 |
| April 16, 2024 | 1.575 |
| April 15, 2024 | 1.568 |
| April 12, 2024 | 1.678 |
| April 11, 2024 | 1.751 |
| April 10, 2024 | 2.032 |
| April 09, 2024 | 2.038 |
| April 08, 2024 | 2.045 |
| April 05, 2024 | 2.038 |
| April 04, 2024 | 1.896 |
| April 03, 2024 | 2.269 |
| April 02, 2024 | 2.402 |
| April 01, 2024 | 2.497 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.311 |
| March 27, 2024 | 2.568 |
| March 26, 2024 | 2.634 |
| March 25, 2024 | 2.605 |
| March 22, 2024 | 2.796 |
| March 21, 2024 | 2.371 |
| March 20, 2024 | 2.311 |
| March 19, 2024 | 1.967 |
| March 18, 2024 | 2.615 |
| March 15, 2024 | 2.284 |
| March 14, 2024 | 1.930 |
| March 13, 2024 | 1.809 |
| March 12, 2024 | 2.022 |
| March 11, 2024 | 1.660 |
| March 08, 2024 | 2.172 |
| March 07, 2024 | 1.746 |
| March 06, 2024 | 1.442 |
| March 05, 2024 | 1.263 |
| March 04, 2024 | 1.192 |
| March 01, 2024 | 1.090 |
| February 29, 2024 | 1.263 |
| February 28, 2024 | 1.339 |
| February 27, 2024 | 1.179 |
| February 26, 2024 | 1.127 |
| February 23, 2024 | 1.025 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5936
Minimum
Oct 31 2023
173.31
Maximum
Jun 11 2020
4.106
Average
1.115
Median
Jun 09 2023
Price to Book Value Benchmarks
| Eyenovia Inc | 5.318 |
| Cassava Sciences Inc | 6.933 |
| Alpine Immune Sciences Inc | 12.91 |
| Clearside Biomedical Inc | -- |
| Poseida Therapeutics Inc | 2.670 |
Price to Book Value Related Metrics
| Price | 6.15 |
| Earnings Yield | -24.06% |
| Market Cap | 66.06M |